Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
This study has been terminated.
( The study was closed early due to low enrollment and new information regarding the benefit of the study regimen. )
Study NCT00314353
Information provided by National Surgical Adjuvant Breast and Bowel Project (NSABP)
First Received on April 11, 2006.
Last Updated on June 8, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
